DB:4HN

Stock Analysis Report

Executive Summary

cocokara fine Inc., through its subsidiaries, engages in the drugstore and pharmacy operations in Japan.

Snowflake

Fundamentals

Flawless balance sheet with proven track record.

Share Price & News

How has cocokara fine's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 4HN has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

2.9%

4HN

-1.1%

DE Consumer Retailing

0.03%

DE Market


1 Year Return

11.2%

4HN

5.4%

DE Consumer Retailing

9.9%

DE Market

Return vs Industry: 4HN exceeded the German Consumer Retailing industry which returned 5.4% over the past year.

Return vs Market: 4HN exceeded the German Market which returned 9.9% over the past year.


Shareholder returns

4HNIndustryMarket
7 Day2.9%-1.1%0.03%
30 Day9.1%-0.07%4.4%
90 Day18.6%6.2%13.6%
1 Year13.0%11.2%9.7%5.4%13.4%9.9%
3 Year65.2%58.7%6.0%-4.2%25.6%14.6%
5 Year197.4%176.5%18.4%0.4%36.9%18.2%

Price Volatility Vs. Market

How volatile is cocokara fine's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is cocokara fine undervalued compared to its fair value and its price relative to the market?

15.29x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 4HN (€53) is trading above our estimate of fair value (€14.36)

Significantly Below Fair Value: 4HN is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 4HN is good value based on its PE Ratio (15.3x) compared to the Consumer Retailing industry average (19.2x).

PE vs Market: 4HN is good value based on its PE Ratio (15.3x) compared to the German market (19.5x).


Price to Earnings Growth Ratio

PEG Ratio: 4HN is poor value based on its PEG Ratio (5.8x)


Price to Book Ratio

PB vs Industry: 4HN is good value based on its PB Ratio (1.6x) compared to the XE Consumer Retailing industry average (1.6x).


Next Steps

Future Growth

How is cocokara fine forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

2.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 4HN's forecast earnings growth (2.7% per year) is above the savings rate (0.2%).

Earnings vs Market: 4HN's earnings (2.7% per year) are forecast to grow slower than the German market (12.5% per year).

High Growth Earnings: 4HN's earnings are forecast to grow, but not significantly.

Revenue vs Market: 4HN's revenue (0.4% per year) is forecast to grow slower than the German market (4.8% per year).

High Growth Revenue: 4HN's revenue (0.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 4HN's Return on Equity is forecast to be low in 3 years time (9.2%).


Next Steps

Past Performance

How has cocokara fine performed over the past 5 years?

21.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 4HN has high quality earnings.

Growing Profit Margin: 4HN's current net profit margins (2.5%) are higher than last year (2.1%).


Past Earnings Growth Analysis

Earnings Trend: 4HN's earnings have grown significantly by 21.5% per year over the past 5 years.

Accelerating Growth: 4HN's earnings growth over the past year (21.3%) is below its 5-year average (21.5% per year).

Earnings vs Industry: 4HN earnings growth over the past year (21.3%) exceeded the Consumer Retailing industry 1.5%.


Return on Equity

High ROE: 4HN's Return on Equity (10.3%) is considered low.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is cocokara fine's financial position?


Financial Position Analysis

Short Term Liabilities: 4HN's short term assets (¥101.7B) exceeds its short term liabilities (¥62.4B)

Long Term Liabilities: 4HN's short term assets (101.7B) exceeds its long term liabilities (8.0B)


Debt to Equity History and Analysis

Debt Level: 4HN is debt free.

Reducing Debt: 4HN has no debt compared to 5 years ago when its debt to equity ratio was 5.6%.

Debt Coverage: 4HN has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 4HN has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet

Inventory Level: 4HN has a high level of physical assets or inventory.

Debt Coverage by Assets: 4HN's debt is not covered by short term assets (assets are -308.2x debt).


Next Steps

Dividend

What is cocokara fine's current dividend yield, its reliability and sustainability?

1.29%

Current Dividend Yield


Upcoming Dividend Payment

Purchase cocokara fine before the 'Buy Limit' to receive their next dividend payment.


Dividend Yield vs Market

company1.3%marketbottom25%1.3%markettop25%3.7%industryaverage3.5%forecastin3Years1.3%

Current dividend yield vs market & industry

Notable Dividend: 4HN's dividend (1.29%) isn’t notable compared to the bottom 25% of dividend payers in the German market (1.33%).

High Dividend: 4HN's dividend (1.29%) is low compared to the top 25% of dividend payers in the German market (3.66%).


Stability and Growth of Payments

Stable Dividend: 4HN's dividend payments have been volatile in the past 10 years.

Growing Dividend: 4HN's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (18.8%), 4HN's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

What is the CEO of cocokara fine's salary, the management and board of directors tenure and is there insider trading?


CEO

Atsushi Tsukamoto (57yo)

11.6yrs

Tenure

0

Mr. Atsushi Tsukamoto serves as Chief Executive Officer and President at KAGA DEVICES CO., LTD. Mr. Tsukamoto serves as Managing Director at ADM Inc. He has been the President of Cocokara Fine Inc. since A ...


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Management Team

  • Atsushi Tsukamoto (57yo)

    President & Representative Director

    • Tenure: 11.6yrs
  • Toru Shibata (63yo)

    VP, GM of Corporate Strategy Division & Director

    • Tenure: 0yrs
  • Tsuyoshi Yamamoto (53yo)

    Head of Planning & Development

    • Tenure: 0yrs

Board Members

  • Akira Torii (70yo)

    External Director

    • Tenure: 0yrs
  • Atsushi Tsukamoto (57yo)

    President & Representative Director

    • Tenure: 11.6yrs
  • Makoto Kitayama (58yo)

    Outside Director

    • Tenure: 9.1yrs
  • Taizo Furumatsu (69yo)

    Director

    • Tenure: 0yrs
  • Toru Shibata (63yo)

    VP, GM of Corporate Strategy Division & Director

    • Tenure: 0yrs
  • Akira Sakamoto (59yo)

    External Director

    • Tenure: 0yrs
  • Tsuyoshi Yamamoto (53yo)

    Head of Planning & Development

    • Tenure: 0yrs

Company Information

cocokara fine Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: cocokara fine Inc.
  • Ticker: 4HN
  • Exchange: DB
  • Founded: 2008
  • Industry: Drug Retail
  • Sector: Consumer Retailing
  • Market Cap: JP¥156.136b
  • Listing Market Cap: JP¥1.299b
  • Shares outstanding: 24.02m
  • Website: https://corp.cocokarafine.co.jp

Number of Employees


Location

  • cocokara fine Inc.
  • Innotech Building
  • 3-17-6 Shin-Yokohama
  • Yokohama
  • Kanagawa
  • 222-0033
  • Japan

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
3098TSE (The Tokyo Stock Exchange)YesCommon SharesJPJPYFeb 2004
4HNDB (Deutsche Boerse AG)YesCommon SharesDEEURFeb 2004

Biography

cocokara fine Inc., through its subsidiaries, engages in the drugstore and pharmacy operations in Japan. It also provides nursing and at-home care services; and operates assisted living homes. In addition, ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/11/16 21:12
End of Day Share Price2019/11/15 00:00
Earnings2019/09/30
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.